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Abstract
Human adult peripheral nerve injuries are a high incidence clinical problem that greatly 
affects patients’ quality of life. Although peripheral nervous system has intrinsic regen-
erative capacity, this occurs in an incomplete or poorly functional manner. When a nerve 
fiber loses its continuity with consequent damage of the basal lamina tubes, axon spon-
taneous regeneration is disorganized and mismatched. These phenomena translate in an 
inadequate nerve functional recovery and consequent musculoskeletal incapacity. Nerve 
grafts still remain the gold standard in peripheral injuries treatment. However, this 
approach contains its disadvantages such as the necessity of primary surgery to harvest 
the autografts, loss of a functional nerve, donor site morbidity and longer surgery pro-
cedures. Therefore, biomaterials and tissue engineering can provide efficient resources 
and alternatives to nerve injury repair not only by the development of biocompatible 
structures but also, introducing neurotrophic factors and cellular systems to stimulate 
optimum clinical outcome. In this chapter, a comprehensive state-of-the art picture of 
tissue-engineered nerve grafts scaffolds, their application in nerve regeneration along 
with latest advances in peripheral nerve repair and future perspectives will be discussed, 
including our own large experience in this field of knowledge.
Keywords: nerve regeneration, peripheral nerve, biomaterials, hydrogels, tube-guides, 
neurotrophic factors, cell-based therapies, functional assessment, mesenchymal stem 
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1. Introduction
Tissue engineering was originally defined by Skalak and Fox, in 1988 [1] as ‘the application 
of the principles and methods of engineering and life sciences towards the fundamental 
understanding of structure-function relationships in normal and pathological mammalian 
tissues and the development of biological substitutes to restore, maintain, or improve func-
tions’. Later, Langer and Vacanti [2], in a widespread review paper, defined three main pil-
lars of tissue-engineering principles, the (a) isolated cells and substitutes—cellular systems; 
(b) tissue-inducing substances—bioactive molecules; and (c) scaffolds, biomaterials and/or 
matrices.
The first strategy concerns cell-based therapies in which cells in a small volume or in cell 
sheets are transplanted into the body. Cellular system includes a wide range of cells and 
most significantly stem cells [3–7]. Stem cells are responsive undifferentiated cells with 
varying degrees of self-proliferation and differentiation plasticity [8]. Although the number 
of stem cells is higher before birth, in adults there are still several ‘niches’ with significant 
number of stem cells [9]. The second pillar focuses on the [5, 7, 10] bioactive molecules that 
can be signalling molecules, proteins and oligonucleotides that can enhance cell migra-
tion, cell growth and/or differentiation. These bioactive molecules are roughly divided into 
mitogens, growth factors and morphogens. Finally, the third pillar is the three-dimensional 
structure that provides shelter and structure for the cellular system [5–7, 11]. Usually, the 
biomaterials or scaffold mimics the environment and natural extracellular matrix (ECM) of 
the place of implantation and should be biocompatible such as their metabolites. Also, scaf-
folds can be used as drug-delivery system in the controlled release of bioactive molecules 
[9, 12, 13].
Biomaterials according to the American National Institute of Health describes ‘any substance 
or combination of substances, other than drugs, synthetic or natural in origin, which can be 
used for any period of time, which augments or replaces partially or totally any tissue, organ 
or function of the body, in order to maintain or improve the quality of life of the individual’. 
Earlier, the Williams Dictionary of Biomaterials [14] defined biomaterial as ‘any substance 
intended to interact with the biological system in order to replace living matter which has 
lost its function. It can serve as a vehicle or not, matrix, support, or for stimulating new tis-
sue growth’. The selection of the most adequate material for a given application should fulfil 
several requirements of physical, mechanical, chemical and biological properties. The most 
important features of biomaterials must be [7] (i) biocompatibility, that is, the biomaterial itself 
must not cause any harm in the living system; (ii) biofunctionality, since the biomaterial must 
feature mechanical and physico-chemical properties adequate to the function and intended 
application; and (iii) sterilizability, while materials must be able to undergo sterilization pro-
cedures, especially the polymeric materials. Biocompatibility is considered the main feature 
of a biomaterial and represents the response of the living system to the introduction of a for-
eigner material. It can be defined as the ‘ability of a biomaterial to perform its desired function 
with respect to a medical therapy, without eliciting any undesirable local or systemic effects in 
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the recipient or beneficiary of that therapy, but generating the most appropriate beneficial cel-
lular or tissue response to that specific situation, and optimizing the clinically, relevant perfor-
mance of that therapy’ [14]. However, biocompatible biomaterials are not useful if they are not 
biofunctional. Similarly, bioactive devices cannot be used if they are not biocompatible. The 
term biofunctionality can be simply explained as the suitability to the function [7]. Scaffold 
porosity is an important desirable feature in the majority of scaffolds, as it promotes cell seed-
ing and cell-matrix interaction and leads to increased neovascularization. However, the exact 
pore size depends on application, the average pore diameter of 20–125 µm is adequate of 
skin tissue and >300 µm, in bone tissue [11, 15]. The macro- and micro-topography and other 
physico-chemical properties of the scaffolds influence cell attachment, migration, prolifera-
tion and differentiation and promote protein and other factors adsorption and therefore the 
success of the system [11, 16]. The mechanical properties and specially the degradation kinet-
ics also is a key feature, especially for musculoskeletal and neuromuscular repair due to the 
slower repair rates.
In this chapter, a comprehensive state of the art of tissue engineering focused on peripheral 
nerve repair and the advances on materials and nerve grafts will be discussed, as well as our 
own large experience in this field of knowledge and the future perspectives.
2. Peripheral nerve regeneration
Peripheral nerve injury remains a major public health problem with an estimated incidence of 
13–23 cases per 100,000 persons [17, 18]. These injuries may have a traumatic or an iatrogenic 
cause and usually are associated with pain, decrease of function and sensory sensibility with 
devastating effects on patients and family lives [3, 17, 19, 20].
Aegineta et al. [21] for the first time performed nerve repair and wound closure in wounded 
soldiers, as a military surgeon. Then, in 1873, Hunter [22] first described the epineural nerve 
repair procedure, still in use today. Sunderland portrayed the principles of nerve repair 
resourcing to microsurgical techniques, and Kurze and Smith were able to apply those prin-
ciples in 1964, thanks to the advance in microscopy [23–25].
Peripheral nerve injuries treatment understands the most challenging surgical procedures, 
and despite the major breakthroughs in this area, complete nerve recovery and nerve func-
tion in all clinical cases have not yet been achieved [17, 20, 26]. Despite the exquisite surgi-
cal techniques, poor recovery outcome results from nervous system intrinsic and extrinsic 
factors, such as the integrity of the surrounding tissues post lesion, type and level of the 
injury itself, the effect on the spinal cord and neurons, the compromising of end organs 
and with key importance the timing of the surgery [17, 27–29]. Also, although periph-
eral nervous system has spontaneous regeneration ability, there is a very limited prospec-
tive of spontaneous recovery, mostly concerning the complete functional neuromuscular 
recovery [20].
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2.1. Peripheral nerve anatomy
The peripheral nerve system is composed by neurons, Schwann cells (SCs), fibroblasts, mac-
rophages and interconnected blood system [20, 30]. Motor and sensory neurons are polar-
ized cells whose bodies reside in the spinal cord and with long cytoplasm called axon. Their 
terminations, called dendrites, target a site of innervation. The signal conduction originates 
in the axon hillock, in the cell body and projects itself in synapses with target end organs. 
Axons plasma membrane is partially enclosed by the SCs that produce myelin that encap-
sulates the axon and helps with signal transmission. Myelin is therefore an insulator that 
enhances the signal transmission efficiency down the axon. Then, there is a connective tis-
sue net that surrounds the individual axons called the endoneurium. An arrangement of 
axons, designed fascicles, is surrounded by the perineurium, and groups of fascicles are 
separated by the epineurium. External to this layer is the blood supply derived from major 
arteries and the latter involved by the mesoneurium (Figure 1). The conservation of fascicles 
patterns and connective tissue is vital for optimal nerve repair and regeneration. Therefore, 
more commonly, the epineurium is sutured in end-to-end suture (called epineural end-to-
end suture), and all nerve surgical interventions are strictly directed at these connective 
tissue layers. The most important feature is the fact that these sutures must be tension free; 
otherwise, they will compromise the nerve blood supply and the process of regeneration 
itself [20, 30–32].
Figure 1. Peripheral nerve anatomy. The figure was adapted from Ref. [30].
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2.2. Nerve response to injury
Nerve injuries can be from a chronic or acute nature, and SCs are the major cause of chronic 
injuries [20, 30]. Acute injuries are mediated by axonal degeneration and occur in a sequence 
of events proximally and distally from the zone of trauma. The initial stages of degenera-
tion occur proximally to the lesion as programmed cell death, called chromatolysis [33, 34], 
and distally to the lesion, through Wallerian degeneration of the distal axonal segment [35, 
36]. Within 24–48 h of the injury, SCs degrade the myelin and phagocytes debris from distal 
axons [37, 38]. The proximal portion of the axon also degenerates up to the node of Ranvier, 
where the axonal regrowth occurs. Then macrophages recruitment occurs, originating growth 
factor release and fibroblast and SCs proliferation. The SCs form organized longitudinal 
structures inside the endoneurium—called bands of Büngner [30, 34]—that are critical to the 
axonal regeneration. At the distal site of lesion, the node of Ranvier, around 50–100 finger-like 
sprouts, starts to form a growth cone directed to the distal nerve stump [39]. Proteases are also 
released from the growth cone by the influence of several factors, clearing the way towards 
the target tissue. Nerve growth factor (NGF), brain-derived growth factor (BDNF) and other 
neurotrophic factors are upregulated by SCs, and their expression is increased which pro-
motes the migration and proliferation of the SCs [20]. Axon existing actin allows axon elonga-
tion and which occurs in a 1–3 mm/day rate [36] until a receptor is reached. If no receptor or 
endoneurial tube is reached, axon continues to grow but in a disorganized manner, causing 
neuroma and clinically painful lesions [40]. In severe nerve injury, axon regeneration is fur-
ther disorganized with additional scaring and pourer regeneration.
2.3. Nerve injury grading
Nerve injuries were firstly classified into neuropraxia, axonotmesis and neurotmesis by 
Seddon [41], after his World War II experience in treating nerve-injured soldiers. Neuropraxia 
is characterized by the segmentation of the myelin without disturbance of the axon, usually a 
consequence of a compression. Typically, it resolves itself, once the myelin is restored, within 
12 weeks. Axonotmesis concerns axonal injury and occurs from a crush mechanism. In this 
case, connective tissue and nerve continuity are not affected but are followed by Wallerian 
degeneration. Axonal regeneration occurs at 1–3 mm/day rate [36], and depending on the 
distance of the lesion, an incomplete recovery may happen. Neurotmesis comprehends the 
anatomical and physiological section of the axons and connective tissues. Therefore, no spon-
taneous regeneration may occur and needs surgical reconstruction [30, 42]. Sunderland later 
expanded this classification by including five types of injury, based on histological knowl-
edge that allowed further distinction between axonotmesis injuries [25, 43]. Sunderland grade 
Type I classification is equivalent to neurapraxia. The Type II, III and IV classifications dif-
ferentiate axonotmesis injuries based on the commitment of the connective tissues. In Type II 
class injury, there is axonal damage without commitment of the endoneurium, and therefore, 
it is possible to achieve a full recovery. In Type III lesions, we find axon impairment affect-
ing the endoneurium, and in Type IV besides endoneurium, there is perineurium damage. 
Sunderland grades III and IV may heal spontaneously, but there is attendant scaring and 
increasing axon and connective tissue damage that causes incomplete recovery. Type IV 
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lesion usually implies surgical intervention and results in extensive scaring. Scars are associ-
ated with pain and nerve conduction impairment and may require reconstructive surgery. 
Type V Sunderland classification corresponds to neurotmesis [30, 42]. Finally, Mackinnon 
and Dellon [44] described a mixed type of lesion degree, a Type VI addition to the Sunderland 
classification. This classification represents probably the most common type of lesions, with 
several layers of injury and not necessarily traditional model as described by Sunderland. 
The recovery potential and also the treatment approach vary, according to the type of lesion, 
considering the three classifications mentioned earlier.
In Table 1, the major findings in nerve injury grading according to Seddon [41], Sunderland 
[25, 43] and Mackinnon and Dellon [44] addition are described.
2.4. Diagnosis
Nerve injury may involve variable lengths of nerve impairment, and the degree of the lesion 
is affected by the type of lesion [45]. Also, the prognosis is dependent on the age of the patient, 
location of the lesion—distal fare better than proximal lesions—and also demographics [42]. 
In terms of nerve electrical signal and electrophysiology, the absence of electrical conduc-
tion may not indicate severe nerve damage, since conduction may be recovered after just 
1 week. Clinical examination (including the functional evaluation) and surgical inspection 
still are the most accurate means to obtain diagnosis. However, non-invasive procedures 
such as nerve conduction studies (NCSs) and electromyograms (EMGs) have a diagnostic 
role in the delayed setting, when muscle fibrillation occurs [30, 42]. NCS assesses both motor 
and sensory functions through a voltage stimulator applied to the skin at different points of 
Sunderland Seddon Characteristics Spontaneous recovery 
potential
Type I Neuropraxia Injury to myelin sheath 
only
Full
Type II Axonotmesis Injuries involve the axon 
only
Full
Type III Axonotmesis Injuries involve the 
axon and disrupt the 
endoneurium
Usually slow or incomplete
Type IV Axonotmesis Injuries involve the 
axon and disrupt the 
endoneurium and 
perineurium
Poor to none
Type V Neurotmesis Complete disruption of the 
nerve; with the epineurium
None
Type VI* Mixed Combination of Types II, 
III and IV
Variable, can be poor to 
none
*Mackinnon and Dellon [44] addition to the Sunderland [25, 43] classification.
Table 1. Nerve injury classification according to Sunderland and Seddon.
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the nerve. A sensor detects response at the muscle (motor function) or nerve (sensory func-
tion). This is the initial screening test for the presence or absence of conduction signal. The 
EMG assesses only the motor function, and in this test, a needle is inserted in the muscle to 
assess the resting electrical activity and voluntary motor unit analysis [30]. In Figure 2, the 
representation of an algorithm of best treating approach selection according to the type of 
lesion, length and also complementary diagnostic results is shown. Sciatic Function Index 
(SFI) is one of the most widely used forms of functional assessment. It compares parameters 
from footprints and mathematically infers about sensory-motor gait function mediated by 
the sciatic nerve, without requiring terminal assessment [46, 47]. Sciatic Static Index (SSI) 
was first introduced by Bervar [48, 49] and is another way of assessing recovery of function 
after sciatic injury in animal models. It also uses the footprints in a static position and mini-
mizes bias related to gait’s velocity. Also, the SSI improves the acquisition of footprints and 
is more repeatable and accurate than the SFI. Other motor performance index is measuring 
Figure 2. Peripheral nerve repair treatment diagram.
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the extensor postural thrust (EPT) and nociceptive function using the withdrawal reflex 
latency (WRL). EPT is induced by lowering the affected hindlimb towards the platform of 
a digital balance supporting the animal by the thorax. During the test, the rat extends the 
hindlimb and the distal metatarsus and digits connect with digital platform balance [50–54]. 
Nociceptive function using the withdrawal reflex latency was described by Masters and 
colleagues [55] and is based on the fact that rats without sciatic nerve injury withdraw their 
paws from the hotplate within 4.3 s or less, when this period of time is increased, it is a 
symptom of impaired nerve conduction [51–53, 56–61]. Nuclear magnetic resonance (RMN) 
imaging could become a valuable tool in nerve injury diagnosis since it allows fine, detailed 
evaluation nerve anatomy and pathology due to excellent image resolution [42]. Also, func-
tional diffusion tensor imaging (DTI), a new diagnosis tool, has been showing peripheral 
nerve sheath tumours; however, its application on differentiating various grades of injuries 
remains to be tested [42].
2.5. Timing of medical intervention
After peripheral nerve injury, repair events begin to take place. Primary repair events occur 
within the first couple of days. However, the rate of axon regeneration is very slow, as previ-
ously referred—it is 1–3 mm/day [36]—and no therapeutic methods have yet improved this 
regeneration rate [30]. However, it is consensual that early nerve repair results in improved 
functional outcomes, as described by Mackinnon and Dellon [44]. Furthermore, there is a set 
period of 12–18 months in which muscle re-enervation can occur before irreversible motor 
end-plate degeneration occurs, and the neurogenic atrophy takes place [30]. Slow axonal 
regeneration associated with muscle structural changes and increasingly degraded stromal 
environment contribute for an incomplete functional recovery. Muscle fibrosis and atrophy 
phenomena begin immediately after denervation and are called neurogenic atrophy. After 
4 months, a plateau is reached, when 60–80% of muscle mass is lost, and although motor 
end plates increase, beyond a 12-month period, a functional muscle re-enervation is highly 
unlikely [30, 39, 62]. The time frame for sensory re-enervation is longer but not endless, and 
early repair also grants better results [30, 39]. In Figure 2, we present the peripheral nerve 
injuries repair algorithm which helps to understand the variables taken into account in the 
selection of best nerve repair strategy.
2.6. Nerve repair strategies
2.6.1. Direct nerve repair
Direct nerve repair with epineural end-to-end sutures using microsurgery techniques is still 
the gold-standard surgical treatment for severe neurotmesis injuries, but only in cases where 
well-vascularized tension-free coaptation can be achieved [30, 37, 63–65]. The procedure 
involves rough fascicular matching between proximal and distal nerve ends and the align-
ment of nerve fascicles and epineural blood vessels [30, 66]. Other types of direct repair consist 
in fascicular repair or grouped fascicular repair. This requires intranerval dissection and direct 
matching and suturing of fascicular groups. Despite better fascicle alignment, this procedure 
is no better than epineural repair in functional outcomes and in fact is associated with more 
traumas and scaring [30, 63, 66]. Complementary assistance techniques of histologic staining 
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using acetylcholine esterase and carbonic anhydrase, electrical stimulation during the proce-
dure in awaken patients and visual observation of surface vessels, are visual orientations to 
the surgeon that grant the success of the procedure [63, 67]. Another possible approach is the 
use of tissue adhesives such as fibrin glue to supplement or replace sutures, creating a gel-like 
clot at the nerve ends. The advantages of this procedure are the efficiency and practicality, the 
reduced trauma and scaring due to a barrier effect. The major disadvantage of this technique 
is the inferior holding strength more subject to stress [63, 68].
2.6.2. Nerve grafts
When peripheral nerve injury originates a significant gap (>3 cm) between the nerve ends with 
excessive tension for direct epineural repair and reversed interposition, nerve grafts are required 
[30, 63]. Such gaps may occur in severe neurotmesis lesions or in axonotmesis stretch injuries in 
which long regions of the nerve may be damaged in the setting of a lesion-in-continuity [63, 69]. 
Nerve grafts are single, cable, trunk, interfascicular or vascularized portions of the nerve with 
similar diameter to the affected [30, 70, 71]. Nerve grafting may be from autologous or allograph 
origin. Xenografts have been described as viable alternatives but require extensive immuno-
suppression and prionic diseases transmission if they are from ruminants [72, 73]. Nerve auto-
grafts are considered the gold standard since they provide appropriate neurotrophic factors and 
viable SCs, both essential for axonal regeneration without immune compromise [63, 74]. For the 
choice of the autologous grafts, many factors must be taken into account, such as the size of the 
nerve gap, the location of proposed nerve repair and associated donor-site morbidity [63, 74]. 
Grafts are either sutured to the epineurium of single nerves or more commonly to the perineu-
rium of individual fascicles, depending on nerve calibre, type and location [30, 63, 74]. The inter-
fascicular nerve graft was described by Millesi et al. [75]. Vascularized nerve graft was designed 
by Taylor and Ham, whereby the donor nerve is transposed with its arterial and venous supply 
into the graft site [76]. Terzis and Kostopoulos [71] clinically demonstrated that medium-sized 
trunk grafts, which would normally undergo central necrosis, could be transferred as vascu-
larized nerve grafts and survive. However, autografts sacrifice a functioning nerve, usually 
a sensory nerve, to substitute a more important injured motor nerve. Therefore, sensory loss 
and scarring at the donor site, where neuroma and pain phenomena, are expected [30, 63, 77]. 
Autologous nerve graft undergoes Wallerian degeneration and therefore just provides support 
and guidance for the ingrowing axon. Also, fascicle mismatch, scarring and fibrosis of the repair 
site is unavoidable and is caused by the injury, tissue handling and suture itself. [30, 63, 77]. 
An alternative to autologous nerve grafting is the use of nerve allografts. The advantages of 
allografts are no donor supply limitations or donor-site morbidity, accessibility and unlimited 
supply of neuronal tissue. However, there are significant costs and complexity with their use, 
such as immunosuppression [30, 63, 72, 73, 77]. Several techniques have been used to reduce 
allograft antigenicity, such as cold preservation, irradiation and lyophilization and certainly 
patients’ immunosuppressive therapy. However, it is proven that immune response is caused 
by SCs, and once their migration has occurred, approximately 24 months after nerve repair, 
systemic immunosuppression can be withdrawn [74, 78]. To avoid immunosuppression, nerve 
allografts are decellularized by a process of chemical detergent, enzyme degradation or irradia-
tion, resulting in an acellular nerve scaffold [30, 63, 79]. Similarly, in tendon transfer, a distal 
function is treated at the expenses of a secondary function [30, 63, 79].
Scaffolds for Peripheral Nerve Regeneration, the Importance of In Vitro and In Vivo Studies...
http://dx.doi.org/10.5772/intechopen.69540
187
2.6.3. Nerve transfers and free-functioning muscle transfer
The definition of nerve transfer is the surgical coaptation of a healthy nerve donor to a dener-
vated nerve [30, 63, 80]. The procedure was first described by Harris in 1921 [81], in the treat-
ment of low median nerve injury suffered during World War I. The major disadvantage is 
finding an expendable donor nerve near the target muscle with a large enough motor fibre 
population [30, 63]. Free-functioning muscle transfer (FFMT) is another treatment approach, 
in severe injuries and especially in secondary reconstructions. The procedure entails the 
transfer of a healthy muscle and its neurovascular pedicle to a new location to assume a new 
function [71, 82]. Since it is a complex procedure, it is only considered as a secondary recon-
structive surgery.
2.6.4. Nerve conduits
Nerve gap repair and nerve grafts have its complications. In the procedures described ear-
lier, the nerve repair requires a second incision site for autograft harvest, donor-site mor-
bidity, loss of a functional, usually sensory nerve, and long-surgery procedure [63, 65]. The 
described disadvantages triggered the development of nerve conduit or nerve guides to 
bring a new approach for nerve gap repair [40, 83]. Also, developments in tissue engineering 
and regenerative medicine, and research in artificial and natural biomaterials have enabled 
the development of the first nerve conduits [73]. Nerve tubulation approach to the repair 
of peripheral nerve gaps can be traced back to the nineteenth century. Gluck (Gluck, 1881) 
performed the first experiment of nerve tabulation, with a tube of decalcified bone to aid the 
approximation of transected nerve ends, in animals [78, 84, 85]. Later, Dahlin and Lundborg 
[86] developed the first synthetic tube, made of silicone. Their work was also pioneer in 
the characterization of the mechanism of regeneration within the lumen of the engineered 
tube [78, 86]. A nerve conduit is a tubular structure made of biological or synthetic mate-
rials designed to bridge the gap of a sectioned nerve. It is used when primary end-to-end 
direct repair is not possible, to protect the nerve from scar formation, to prevent fluid from 
leaking from the nerve stump and to guide the axon nerve cone into the distal nerve stump 
[63, 65, 78]. The fluid formed from the transected nerve ends is essentially made of fibrin, 
which forms a matrix or a hydrogel matrix between the nerve ends that is able to support 
cell migration. Cell migration within the fibrin matrix creates some linear bands—bands of 
Büngner—that steer the growth of the nerve cone [78, 86]. The mechanism through which 
neurite growth cone forms within the lumen of the conduit depends on the volumetric ratio 
[87, 88]. If the gap is too long or the diameter of the inner lumen is too large, the growth cables 
are too thin, and due to the fibrin matrix, the growth cone takes on an hourglass figure that 
affects axonal regeneration. Nectow et al. [89] also studied the effect of the defect size in the 
regenerative process through nerve conduits. Nerve conduits provide control environment to 
outgrowing axons, migration of SCs and neurotrophic stimulation by the distal stump crucial 
for optimal regeneration of nerve function [40, 90]. This approach is usually reserved for gap 
defects between 1.5 and 3 cm [91, 92]. As early as 1994, Brunelli et al. [91] defined four factors 
for an ideal nerve conduit material: (i) biocompatibility, (ii) easy preparation and tailoring, 
(iii) incorporation of neurotrophins and stimulating substances, and (iv) protection against 
scaring. Recently, Arslantunali et al. [93] defined the desirable features for a nerve conduit, as 
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flexibility, biocompatibility, biodegradability, high porosity, neuroinductivity, neuroconduc-
tivity, easy handling and sufficient endurance. Nowadays, the second- and third-generation 
nerve conduits are becoming Food and Drug Administration (FDA) approved and reaching 
the marked, so, many more pre-clinical and clinical trials are demonstrating major break-
through in this area. In Figure 3, we represent the major features of nerve conduits, and the 
modification researchers have made to introduce neurotrophic elements that enhance nerve 
regeneration and peripheral nerve repair.
2.6.5. Biological conduits
The use of non-neuronal tissue as conduits was first reported by Büngner (Büngner, 1891), 
when he successfully used a segment of human brachial artery to regenerate a gap in sciatic 
nerve [84]. The use of arterial grafts has been demonstrated [94, 95] but is associated with high 
morbidity. Also, lack of donor vessels makes this a less popular approach in nerve repair. 
However, it has been described that neurovascular injuries in the hand have benefited from 
the use of homolateral arteries in the repair [40, 84]. Frerichs et al. and Kim at al. [96, 97] have 
used acellular allogenic nerve grafts effectively in the regeneration nerve gaps in a rat sciatic 
model. A similar approach was approved by such Food and Drug Administration and is com-
mercially available as Avance®, by AxoGen, Inc. (Alachua, FL, USA) (Table 2). Veins have 
also been a viable option for nerve repair. The risk of vein collapse led to their filling with 
Figure 3. Different types of nerve conduits and their main features. Nerve conduits modification that functions as nerve 
regeneration enhancers.
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nerve or muscle tissue. This supplementation has the added advantage of supplying neuro-
trophic factors and ECM (muscle fibres) and has been described to facilitate nerve regenera-
tion across longer gaps by promoting SCs migration, cell proliferation and guidance of the 
axonal growth cone [84]. Another type of biological conduit is tendon autograft. Although 
with only theoretically and historic interest, ECM macrostructure and the presence of hyal-
uronic acid have been described to enhance regenerating in the nerve cone [84]. AxoGuard™ 
is the only FDA-approved device composed by small intestine submucosa (SIS) extracellular 
matrix (Table 2). Preliminary studies in rat sciatic model showed distally directed growth of 
the proximal nerve [98]. Later further in vivo studies revealed better EMG response for distal 
motor latency and amplitude [99].
2.6.6. Manufactured conduits
Manufactured nerve conduits can be divided as first-, second- and third-generation conduits. 
The first-generation conduits are non-resorbable, synthetic tubes made of silicone or polytet-
rafluoroethylene (ePTFE, Gore-Tex®) [65]. These conduits require a second surgery in order 
to remove the non-resorbable material. The original idea was to provide support, structure 
to guide axonal regrowth and form a stable barrier against connective tissue infiltration [73, 
100, 101]. Synthetic nerve conduits made of ePTFE were successfully applied in a 4-cm nerve 
gap, in human [102]. Second-generation nerve conduits are resorbable, biocompatible tubes 
and are FDA approved and commercially available through different materials. The main 
advantage of these conduits is their permeability and resorbability that spares patients of a 
second surgery procedure. Third-generation nerve conduits contrary to second-generation 
may incorporate controlled release/delivery of neurotrophic factors, electroconductive mate-
rial, stem cells or SCs, extracellular matrix proteins, surface micropatterning or luminal fillers 
[73, 103]. Already, two third-generation products have been approved by the FDA, namely 
NeuraGen® 3D from Integra LifeSciences Corporation and Nerbridge from Toyobo Co., 
Ltd. NeuraGen® 3D (K130557, approved in 2014) is a bovine Type I collagen conduit with 
a porous inner hydrogel matrix of collagen and glycosaminoglycan (chondroitin-6-sulfate). 
Nerbridge™ (K152967, approved in 2016) is a flexible, resorbable and semipermeable tubular 
membrane matrix filled with porous collagen that provides a non-constricting encasement for 
injured peripheral nerves for protection of the neural environment.
2.7. Materials
2.7.1. Collagen
Denaturated collagen conduits are available from a wide number of manufacturers and are in 
fact the most exploited material in nerve conduits [73, 78]. Collagen is a structural protein ubiq-
uitous in the human body, particularly in the peripheral nerve system. Also, collagen supports 
cell proliferation and tissue regeneration [65, 73, 104]. As nerve conduits collagen allows the 
establishment of topographical cues that guide axons to regrow [105, 106] and has shown excel-
lent cell adhesive properties that encourage cell attachment and proliferation [106, 107]. The 
degradation time of the collagen conduits is relatively prolonged and takes up to 48 months 
which can cause nerve compression and fibrosis [84]. The first commercially available collagen 
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Name Composition Structure Length (cm) Degradation Time 
(months)
Manufacturer FDA approval
NeuroTube Polyglycolic acid Absorbable woven mesh 
tube
2–4 3 Synovis Micro 
companies
1999
Saluleridge nerve 
cuff
Polyvinyl alcohol Flexible tubular 
membrane
6.35 No degradation Salumedica LLC 2000
NeuraGen Collagen Type I Fibrillar, semipermeable 2–3 3–4 Integra LifeSciences 
Co.
2001
NeuroFlex Collagen Type I Flexible, Semipermeable 
and tubular
2.5 4–8 Collagen Matrix, 
Inc.
2001
NeuroMatrix Collagen Type I Flexible, Semipermeable 
and tubular
2.5 4–8 Collagen Matrix, 
Inc.
2001
Surgesis nerve cuff Type I, III, IV and VI 
collagen
Extracellular collagen 
matrix
5 Reabsorbable Cook Biotech 2003
Neurolac Poly-dl-lactide-
caprolactone
Tubular 3 16 Polyganics BV 2003/2005
NeuraWrap Collagen Type I Flexible, Semipermeable 
longitudinal slit
2–4 36–48 Integra LifeSciences 
Co.
2004
NeuroMend Collagen Type I Semipermeable wrap 
that curls and enrols
2.5–5 4–8 Collagen Matrix, 
Inc.
2006
SaluTunnel Polyvinyl alcohol Tubular 6.35 No degradation Salumedica LLC 2010
Avance Processed human nerve 
allograft
Tubular Variable No data AxoGen, Inc. 2010
Cova 
ORTHO-NERVE
Type I collagen Rollable membrane 2.5–6 3–4 Biom’Up S.A. 2012
AxoGuard Extracellular matrix 
derived from porcine 
intestine
Semipermeable, and 
absorbable tube
Variable No data AxoGen, Inc. 2013
Flexible Collagen 
Nerve Cuff
Collagen Type I Flexible, Semipermeable 
and tubular
2.5 No data Collagen Matrix, 
Inc.
2014
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Name Composition Structure Length (cm) Degradation Time 
(months)
Manufacturer FDA approval
Nerve cuff Type I, III, IV and VI 
collagen
Extracellular collagen 
matrix
1–5 Reabsorbable Cook Biotech 2014
Neuragen 3D Type I collagen and 
glycosaminoglycan 
(chondroitin-6-sulphate)
Flexible, pliable 
tube with collagen-
glycosaminoglycan inner 
matrix
6.35 9–12 Integra LifeSciences 
Corporation
2014
Reaxon Plus Chitosan Flexible, pliable tube 3 3 MEDOVENT GmbH 2015
Nerbridge polyglycolic acid and 
Type I and III collagen
flexible, semipermeable 
tubular membrane filled 
with porous collagen
3–5 3–4 TOYOBO CO., LTD. 2016
Table 2. Commercially available and FDA-approved nerve conduits.
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nerve conduit was NeuraGen®, from Integra Lifesciences, Princeton, NJ, FDA approved in 2001 
(Table 2). Several studies regarding the efficacy of collagen conduits in peripheral nerve inju-
ries have been stated. Bushnell and colleagues [108] performed in 2008 a retrospective study of 
the utilization of collagen conduits in digital sensory nerve gaps of up to 20 mm and demon-
strated a significant recovery rate of 89%. In a retrospective review, Wangensteen and Kalliaine 
[109] reported on a large number of sensory nerve gaps of 2.5–20 mm repaired with collagen 
conduits in multiple body regions and concluded that clinically successful outcomes were only 
observed in 43% of the cases. A prospective cohort study was performed by Lohmeyer and col-
leagues in 2009 [110] in digital and palmar nerve gaps of 6–18 mm, and results showed mean-
ingful recovery in 75% of patients. Later, in 2011, Taras et al. [111] reported a 73% meaningful 
recovery in 5- to 15-mm isolated digital nerve lacerations repaired with collagen conduits. In a 
niche approach, collagen conduits have been used in children suffering from plexus brachialis 
injury during birth [112]. Also, a significant number of in vivo studies on collagen conduits 
showed good functional outcomes in nerve reconstructions in rat, cat, dog and primate models 
[113–115]. Researchers and surgeons have, however, raised their concern about these conduits 
due to its high cost, conduit stiffness, lack of flexibility and poor enhancement of nerve regen-
eration [116, 117]. Also, collagen conduit application on major peripheral nerve injuries is lim-
ited to median and ulnar nerve repairs at the wrist and only observed as an alternative to the 
classic epineural suture repair [78]. In a recent study, Monaco and colleagues [118] investigated 
the effect of three different sterilization methods, dry heat, ethylene oxide and electron beam 
radiation, on the properties of cylindrical collagen scaffolds with longitudinally oriented pore 
channels, specifically designed for peripheral nerve regeneration. Ethylene oxide exposure 
demonstrated to be the most suitable method for the sterilization of the proposed scaffolds, 
since β-sterilization significantly augmented scaffold enzymatic degradation. Currently, there 
are 10 commercially available and/or FDA-approved collagen nerve conduits (Table 2).
2.7.2. Fibrin
Fibrin is a fibrous, non-globular protein involved in the clotting of blood. It is a commonly 
used biomaterial as fibrin glue in nerve repair. Nonetheless, it can also be engineered into a 
hydrogel with aligned matrix or shaped into tubular conduits [84]. As fibrin glue, it is widely 
used in sutures, thanks to its semisolid structure that enhances haemostasis and integrity of 
the repair and also due to its angiogenesis, chemotaxis, leucocytosis and macrophage pro-
liferation stimulation [119, 120]. When used in a conduit, fibrin has shown to promote axon 
regeneration and functional recovery in small gaps [116, 121, 122]. Rafijah and colleagues 
[123] have reported the use of collagen conduits filled with fibrin glue in 10-mm rat sciatic 
nerve defect. After 12 weeks, no inhibitory effect was observed on function, axonal regenera-
tion and compound motor action potential compared to hollow collagen conduit.
2.7.3. N-fibroin
N-fibroin is a soluble protein, derived from silk with great potential due to their superior 
biocompatibility and low immunogenicity and mechanical stability upon degradation [73, 
124]. Several studies have demonstrated the potential of N-fibroin in the regeneration of 
peripheral nerve injuries [124–128]. Silk fibroin-based nerve guidance conduit with oriented 
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filaments was produced by Yang and colleagues [129] and originated successful results in rat 
sciatic model. Researchers have also shown that silk-based conduits [130] and silk nanofibres 
[131] enhance cell-material interactions like cell adhesion, proliferation and differentiation. A 
new approach entails the development of conduits with multi-walled silk fibroin/silk sericin 
internal lumen, beneficial to nerve regeneration and outer sheath (the hollow poly(lactic-co-
glycolic acid) conduits that provide strong mechanical protection. Engineered bionic conduit 
showed promising in vivo results [132]. Research has also reported the development of silk 
fibroin conduits loaded with nerve growth factors [133–138]. Despite the promising results, 
no silk conduit has yet been FDA approved.
2.7.4. Chitosan
Chitosan is a natural polymer currently under investigation as nerve conduits due to its 
favourable biocompatibility, biodegradability and bioactivity [139]. Our group research 
tested the nerve-regenerative potential of chitosan membrane with N1E-115 cellular system in 
rat sciatic nerve crush injury. Results showed that freeze-dried chitosan Type III without N1E-
115 cell addition was the only type of membrane that significantly improved post-traumatic 
axonal regrowth and functional recovery [52]. Recent study showed meaningful motor and 
sensory recovery in 30-mm defect in the nerve of the distal right forearm [140].
2.7.5. Polyglycolic acid
Polyglycolic acid (PGA) was the first FDA approved and commercially available nerve con-
duit—NeuroTube®, from Synovis Micro Companies Alliance, Birmingham, Ala. PGA is a com-
mon suture material and is more flexible and porous than silicone. PGA is degraded into lactic 
acid in 6–12 months [73, 90]. Therefore, critics claim that PGA may degrade faster than the 
regeneration process and resulting lactic acid may a have toxic effects [84, 141–143]. Dellon 
and Mackinnon [144] were the first to report the use of PGA conduits as secondary reconstitu-
tion of digital nerve defects 3 cm or smaller in 15 clinical cases in monkeys. After 1 year, 86% 
meaningful recovery was reported. Later, in an attempt to compare PGA conduit results to 
conventional autograft repair, Weber et al. [145] conducted a randomized prospective multi-
centre trial in the reconstruction of long sensory nerve gaps up to 3 cm. After 1 year, 74% mean-
ingful recovery was noted in the PGA group compared with 86% in the standard techniques 
group (P > 0.05). Further analysis showed that PGA conduits were equivalent or superior to 
traditional autografts in less than 4- and 9–30-mm gaps [145]. Other researchers also compared 
PGA conduits and vein grafts to repair digital nerve gaps up to 4 cm and equivalent or supe-
rior recovery was obtained [146, 147]. Further experiments have demonstrated the success of 
bioabsorbable PGA nerve conduits in the regeneration of nerve defects [148–151]. The most 
recent FDA-approved PGA conduit is Nerbridge®, from Toyobo Co., Ltd., which is a flexible, 
semipermeable tubular membrane filled with porous Type I and III collagens (Table 2).
2.7.6. Poly (d, l lactide-co-ε-caprolactone)
Poly-d, l lactide-co-epsilon-caprolactone (PCL) consists in lactic acid and caprolactone mono-
mers. Their nerve conduits are resolvable polyester with the advantage of being transparent and 
with less acidic degradation product that therefore causes less toxic reaction [60, 84, 116, 152]. 
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Also, PCL conduit is easy to produce, has a low-cost processing and has a long degradation 
time up to 16 months. However, resulting conduits have higher rigidity and more difficult to 
handle in clinical settings [84]. Also, Duda et al. [153] reported a strong foreign body response in 
PCL conduits. Currently, Neurolac® [154–156] is the only FDA-approved caprolactone conduit 
(Table 2). Several reports have been made in the application of PCL conduits in sciatic rat nerve 
repair [157–162]. Bertleff et al. [154] performed a randomized prospective multicentre study 
where PCL conduits were comparable to either primary end-to-end repair or nerve autograft. 
However, latter research showed no meaningful recovery in digital nerves repair [155, 156]. 
Secer and colleagues [163] studied the use of PCL in the recovery of 455 patients with ulnar 
nerve injuries. PCL conduits filled with muscle tissue showed superior results in comparison to 
single PCL conduits in 10- and 15-mm gap in sciatic nerve rat model [36, 156, 164–168].
2.7.7. Polyhydroxybutyrate
Polyhydroxybutyrate (PHB) is a polyester polymer, also used in sutures and wound dress-
ings [116, 169]. PHB has a long degradation time, up to 24–30 months [116, 169]. It has been 
reported that PHB has a neuroprotective effect and can help axon regeneration [170, 171]. 
Recently, Axongen Pharmaceuticals has a pending approval order of a PHB conduit. A study 
in which PHB wrap implants were used in human patients showed promising results com-
pared to epineural suture [172].
2.7.8. Polyvinyl alcohol
Polyvinyl alcohol (PVA) [36, 89, 93] is the only nondegradable synthetic nerve conduit 
approved by the FDA—SaluBridge and SaluTunnel, from SaluMedica LLC, Atlanta, GA, USA 
(Table 2).
2.7.9. Polyhedral oligomeric silsesquioxane
Polyhedral oligomeric silsesquioxane (POSS) can be described as the smallest particles of silica 
[116]. The combination of POSS and PCL has been employed in the fabrication of peripheral 
nerve conduits and in vivo clinical studies to show the potential translation into clinics [117].
2.8. Optimizing nerve regeneration
Although nerve conduits provide sufficient guidance for regeneration of nerve defects, the 
development of new generation of scaffolds is under way. Third-generation conduits include 
artificial conduits that may incorporate controlled release/delivery of neurotrophic factors, 
electroconductive material, stem cells, SCs, extracellular matrix proteins, surface micropat-
terning, luminal fillers and guidance structures [73, 103].
2.8.1. Conduits structure modulation
Surface micropatterning and the inclusion of extracellular matrix proteins are new approaches 
that can provide suitable nanostructure topography for adequate neural growth and simulate 
topographical dimensions that mimic native nerve extracellular matrix [103, 173]. Coating of 
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peripheral nerve conduits can enhance nerve regeneration process and solve longer nerve 
gaps repair. Resource to extracellular matrix materials, such as fibronectin, laminin and col-
lagen, give naturally hydrophobic scaffolds a hydrophilic surface that promotes cell adhesion 
[73, 116, 174]. Collagen Type I conduits coated with laminin and fibronectin have shown 
improved neural regeneration [175, 176]. With that intend, new peptides have been engi-
neered to mimic the active binding domains of various extracellular matrix molecules [177, 
178]. Coating with arginylglycylaspartic acid (RGD) sequences (the tripeptide Arg-Gly-Asp) 
also obtained very good results [117, 179–182]. Structure pore design is a great strategy to 
promote nerve regeneration. Controlling the architecture of the conduit wall is possible to 
develop a microporous inner layer and macroporous outer layer and obtain a bidirectional 
permeability [86, 103]. The diameter of the pores plays a critical role in the efficiency of the 
scaffolds since it influences cell attachment, axon regeneration and diffusion of nutrients [183, 
184]. Electrospinning is a frequently used technique in bioengineering to produce imprinted 
micropatterns and can be used as a luminal guidance strategy. The advantages associate with 
electrospun conduits are (i) highly flexible and porous materials; (ii) high surface area-to-vol-
ume ration, thereby great availability for protein absorption, stem cells migration and regen-
eration of axons; (iii) fibers can be preferentially aligned, resulting in increased SC alignment, 
proliferation and growth, and the promotion of guided axonal growth [116, 185, 186]. Uneven 
fibre distribution and nerve growth inhibition caused by fibre overlapping are some of the 
disadvantages associated with this type of conduits. However, association with wall guides 
helps to avoid this problem [105, 187, 188].
2.8.2. Luminal fillers
Biomaterials and other strategies as conduits luminal fillers aim to change its microenviron-
ment in a favourable way. The goal of this strategy is to promote axon regeneration inside the 
conduit and the restoration of motor and sensory nerve function.
2.8.2.1. Cellular systems
Stem cell therapies have received increased attention in regenerative medicine [189–201]. 
The use of cellular systems inside nerve conduits is intended to promote axon regeneration 
[202–206]. Several cells have been used with this intention, SCs, bone marrow stem cells 
(BMSCs) including more specifically the mesenchymal stem cells (MSCs). SCs are the natu-
ral glia of the peripheral nervous system and have been used successfully with beneficial 
effects in nerve reconstruction [204, 207–210]. However, there is limited availability, and 
it requires previous surgery. Stem cells have the opportunity to show their potential since 
they are able to secrete neurotrophic factors and provide a favourable microenvironment 
for neurogenesis and the proliferation of SCs in peripheral nerve repair [211] and also are 
able to differentiate into Schwann cell-like phenotype [200, 212, 213]. MSCs therefore seem 
the most attractive approach as cellular system in peripheral nerve regeneration. MSCs all 
share mesenchymal markers that differentiate them from other cells that are positive stain-
ing for CD10, CD13, CD29, CD44, CD90 and CD105, and negative expression of haemato-
poietic markers [214]. Their main feature is their ability to proliferate and self-renew in a 
sustained manner, high plasticity and low immunogenicity, and differentiate into multiple 
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mesodermal cells,  including neuron-like cells [215, 216]. Also, they are major histocompat-
ibility complex (MHC) class II negative and also their MHC class I expression levels can be 
manipulated; therefore they do not require the use of immunosuppressive drugs [217, 218]. 
MSCs can be isolated from several origins, including skin, hair follicle, periosteum, amniotic 
fluid, umbilical cord blood adipose tissue and dental pulp [53, 56, 200, 215, 219–221]. Bone 
marrow represents the most commonly used tissue source of adult MSCs. BMSCs have lim-
ited availability especially in adult life and there is donor-site morbidity associated with its 
harvesting. Therefore, alternative sources have been reached. MSCs exist in the connective 
tissue (Wharton’s jelly (WJ)) of human umbilical cord and can be harvested easily [214, 218, 
222, 223]. Several researchers have demonstrated that umbilical cord–derived stem cells can 
be differentiated into neuronal phenotype [214, 218, 222, 223] and have demonstrated poten-
tial utility in neurodegenerative diseases [224, 225]. Our group research has vast experience 
in the application of mesenchymal stem cells in peripheral nerve regeneration [50, 52, 53, 
56–61]. In our most recent work [56], we report the therapeutic value of MSCs isolated from 
the Wharton jelly in nerve repair associated to different tube guides made of biodegradable 
and biocompatible biomaterials. Biomaterials like PVA, PVA loaded with functionalized car-
bon nanotubes (PVA-CNTs), PVA loaded with polypyrrole (PVA-PPy) and PLC associated to 
MSCs were tested in terms of cytocompatibility and in vivo in the rat sciatic nerve neurotme-
sis injury model. The functional recovery was assessed serially for gait biomechanical analy-
sis, by EPT, SFI and SSI, and by WRL. Results showed that MSCs enhanced the recovery of 
sensory and motor function in neurotmesis injuries showing a thicker myelin sheath. Other 
authors have reported the application of bone marrow stem cells and Schwann-like cells in 
the regeneration of facial nerves in rats [219].
Other sources of stem cells have been used in peripheral nerve injuries, such as adipose-derived 
stem cells [203, 206, 212, 226–231] and dental pulp stem cells (DPSCs) [232–236]. Dental pulp 
stem cells have also demonstrated differentiation capacity towards multiple other mesoder-
mal and endodermal lineages, under appropriate conditions: adipogenic, osteo/dentinogenic, 
chondrogenic, neurogenic, endothelial, myofibroblastic [237] and hepatocytes [238]. DPSCs 
can be isolated from both the perivascular and the sub-odontoblastic compartments (the inner 
surface of the tooth and the outer part of the pulp tissue), by separate digestion of the tooth 
and extracted pulp tissue. Both populations presented identical cell size, doubling times and 
karyotype stability, differing only in morphology with rounder cells in the sub-odontoblastic 
compartment versus spindle-shaped cells with long processes in the perivascular one [239]. 
Pre-clinical experiments have demonstrated that stem cells show promising results in differ-
entiation into neuronal-like cells [226, 228, 232, 233, 240] and their secretion of growth factors 
[229, 241, 242]. Shi and colleagues [243] stated the potential of glia-derived neurotrophic fac-
tor expressing neural stem cells in the regeneration of facial nerve gap in rats.
2.8.2.2. Neurotrophic factors
Growth factors and cytokines have a complex enhancing effect in tissue regeneration which 
can be exploited with great potential in nerve regeneration [73]. To date, several neuro-
trophic factors have been identified: transforming growth factor beta superfamily (TGF-β), 
nerve growth factor, neurotrophins 3, 4 and 5 (NT-3/4/5), ciliary neurotrophic factor (CNTF), 
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 neuregulin-1 (NRG1), brain-derived neurotrophic factor, glial cell line–derived neurotrophic 
factor (GDNF) and vascular endothelial growth factor (VEGF). The controlled release of the 
neurotrophic factors in nerve conduits may take several approaches, namely topical appli-
cation, subcutaneous injection, microosmotic pump and diffusion or affinity-based polymer 
microspheres [244–251]. In another approach, Cui and colleagues [252] loaded the neuro-
trophic factors into the wall of the nerve conduit with controlled diffusion into the lumen. 
NGF has been reported to promote neurite outgrowth in vitro in co-culture of neurons and 
astrocytes [253] and in vivo–enhanced axonal regeneration in sciatic nerve in rat model [248, 
254]. Several researchers have demonstrated BDNF efficacy in the regeneration of rat motor 
nerves [253, 255, 256]. The dosage of BDNS has also been studied [257]. A high dosage, set 
as 12–20 mg/day, has been stated to interact with p75 receptors and therefore inhibits axo-
nal regeneration. In fact, single exogenous dosage of BDNF has shown better results than 
continuous long-term applications [258]. It is reported that muscle regeneration causes the 
overexpression of GDNF which increases the number of motor axons in the neuromuscular 
junctions in vivo [259–266]. Also, GDNF is a potent protective factor against axotomy-induced 
motor and sensory neuron death [267–270]. CNTF has the ability to improve and regener-
ate muscle function after nerve injury in vivo [271, 272]. It has also demonstrated to enable 
peripheral nerve regeneration by promoting axon elongation and sprouting from axon distal 
stump [273]. Six main isoforms of NRG-1 are described. Due to their importance in nerve 
regeneration isoforms I, II and III are the most studied in the last few years [274]. Nerve-
regenerative effect of NRG-1 is highly dependent on the isoform and its dosage [275, 276]. 
Several studies indicate that NRG-1 isoforms are capable of stimulating SCs proliferation a 
remyelinization [275–278]. Gambarrota and colleagues [279] recommended that initial high 
dosages of NRGA-1 stimulate SCs differentiation.
2.8.2.3. Pharmacological agents
Until now, there is no pharmacological method that can effectively enhance nerve regeneration. 
However, as mentioned earlier, neurotrophic and growth factors have demonstrated potential 
in enhancing nerve repair and regeneration by reducing neuronal death and promoting axonal 
outgrowth. Recent advances in molecular biology have indicated that targeting specific steps 
in molecular pathways may allow for purposeful pharmacologic intervention, potentially 
leading to a better functional recovery after nerve injury [63, 280]. Major molecular pathways 
implicated in neuron survival and neurite outgrowth include PI3K (phosphatidylinositol-3 
kinase)/Akt (protein kinase B)-signalling cascade, Ras-ERK (rat sarcoma-extracellular signal-
regulated kinase) pathway, the cyclic adenosine monophosphate (cAMP)/protein kinase A 
(PKA) and Rho-ROK signalling [280]. PI3K/Akt cascade seems to provide trophic support 
for neurons, block apoptosis, facilitate signal transmission and mediate cell growth and dif-
ferentiation in neurons. Also, it is reported that NGF is mediated by PI3K/Akt/mTOR path-
way [281–283]. Ras-ERK pathway is a key promoter of neurite outgrowth and also has been 
found to enhance axonal survival [284]. Rho–ROK pathway participates in neural growth and 
modulates neurite outgrowth [285]. Nectins and nectin-like molecules are cell-cell adhesion 
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molecules that participate in cell communication. Nectin-like molecule 1 (NECL1) is restricted 
to the nervous system and is responsible for the synapses formation, axon bundles, myelin-
ated axons and cerebellar morphogenesis [286, 287]. In a recent study, Xu and colleagues [288] 
developed a PLGA scaffold coated with NECL1 to enhance adhesion of rat SCs and applied 
in the treatment of transected sciatic nerve in rat. Results also revealed that the final outcome 
of both motor and sensory regeneration and reinnervation. Other molecules with different 
clinical applications have, however, demonstrated beneficial effect in nerve regeneration pro-
cess: erythropoietin (EPO) [289], tacrolimus (FK506) [290], acetyl-L-carnitine (ALCAR) [291], 
N-acetylcysteine (NAC) [292], ibuprofen [293], melatonin [294] and transthyretin [295].
2.8.2.4. Channels
The use of longitudinal channels inside nerve conduits is the usual strategy to promote axon 
guidance towards distal stump. The artificial micro-tubular structure mimics the endoneural 
tubes and fascicles of a peripheral nerve anatomy and therefore enhances neuroregeneration 
[296–298].
2.8.2.5. Hydrogels
As described earlier, conduits lumen can be filled with ECM components such as collagen 
and laminin which are involved in the process of regeneration by forming a substrate for 
neuron cell migration. Laminin-filled silicone conduits have demonstrated enhanced nerve 
regeneration [299, 300]. Collagen has also demonstrated to increase nerve regeneration [301]. 
BD Matrigel® and other lamini and collagen gels have been widely used as conduit fillings to 
incorporate or support cells and neurotrophic factors [302–304].
2.8.2.6. Conductive conduits
Electrical stimulation as a therapeutic in nerve injuries has been widely discussed in the aca-
demic community [305–313]. External electrical stimulation as peripheral nerve regeneration 
strategy has been demonstrated. Several conductive polymers such as polyaniline (PANI) 
and polypyrrole have been described with great potential for nerve regeneration due to their 
biocompatibility, tuneable conductivity, environmental stability and facility to produce. The 
great advantage of this material is the ability to continue to transmit the electrical signal in 
impaired nerves and physically stimulate cell growth and regeneration [314–316].
2.9. Future perspectives
Gene therapy involves the introduction of a foreign gene into living cells with the inten-
tion to overcome a disease [317]. The most efficient way to deliver transgenes into cells is 
through a vector, such as herpes simplex, adenovirus, lentivirus and adeno-associated viral 
vectors [318, 319]. Gene can reprogramme cells to produce neurotrophic factors, cell adhesion 
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or extracellular matrix molecules, and transcription factors. Therefore, in peripheral nerve 
injury, Schwann cells, fibroblasts and denervated muscle are potential targets for this break-
through approach [63].
Bioactive glasses have been widely used as bone-filling materials and dental implants and 
have demonstrated its potential in soft-tissue regeneration. A comprehensive study on the 
application of bioactive glass in peripheral nerve regeneration has been conducted by Novajra 
and colleagues [320, 321]. Polymer-glass composite devices are made with bioactive glass 
powder and successfully applied in peripheral nerve repair. In other approach, this material 
can be used as fibres to produce nerve wraps, topographic patterns at conduit lumen or guid-
ance channel to guide axonal growth. Their major advantage is the ions release from bioactive 
glasses, which have demonstrated angiogenic effects and the possibility of manipulation of 
glass composition; I order to include antibacterial ions, such as silver, gallium, zinc and cop-
per, that can be useful in the prevention and treatment of infections resulting from the clinical 
intervention.
In conclusion, the vast field for improvement in peripheral nerve regeneration strategies has 
been well recognized. The ideal therapeutic alternative should be readily available, able to 
confine and direct axonal growth and be biofunctional, by the supplementation with bioactive 
molecules and/or cellular systems. Therefore, there is scope for improvement in the develop-
ment of new and better alternatives of bioactive peripheral nerve repair complexes.
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GDNF Glial cell line-derived neurotrophic factor
MHC Major histocompatibility complex
MSCs Mesenchymal stem cells
NAC N-acetylcysteine
NCS Nerve conduction studies
NGF Nerve growth factor
NRG1 Neuregulin-1
NT-3/4/5 Neurotrophins 3, 4 and 5
PANI Polyaniline
PCL Poly d, l lactide-co-epsilon-caprolactone
PGA Polyglycolic acid
PHB Polyhydroxybutyrate
PI3K Phosphatidylinositol-3 kinase
PKA Protein kinase A
POSS Polyhedral oligomeric silsesquioxane
Scaffolds for Peripheral Nerve Regeneration, the Importance of In Vitro and In Vivo Studies...
http://dx.doi.org/10.5772/intechopen.69540
201
PPy Polypyrrole
PVA Polyvinyl alcohol
PVA-CNTs PVA-functionalized carbon nanotubes
Ras-ERK Rat sarcoma-extracellular signal-regulated kinase
RGD Arginylglycylaspartic acid
SC Schwann cells
SFI Sciatic Functional Index
SIS Small intestine submucosa
SSI Static Sciatic Index
TGF-β Transforming growth factor beta superfamily
VEGF Vascular endothelial growth factor
WJ Wharton jelly
WRL Withdrawal reflex latency
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